Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about James Lanthier Recent news which mentions James Lanthier Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials October 07, 2022 Tickers MSSTF Tags psilocin Penny Stocks Benzinga From Benzinga Cybin Acquires Exclusive License To Mindset Pharma's Tryptamine Compounds Family September 27, 2022 Tickers CYBN MSSTF Tags Penny Stocks James Lanthier Benzinga From Benzinga Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close? September 14, 2022 Tickers MSSTF Tags Clinical Trial Authorization Guidance Markets From Benzinga Psychedelics Companies Explore & Protect Their Findings, This Firm Is Doing That In 16 Countries September 07, 2022 Tickers MSSTF Tags Global Penny Stocks Benzinga From Benzinga This Company Just Created 3 Brand New Psychedelics—Without The Hallucinogenic Side Effects August 31, 2022 Tickers MSSTF Tags Market News Cannabis Global From Benzinga Intranasal Psychedelics Platform Is Here, Check Out Mindset's New Development June 30, 2022 Tickers MSSTF Tags Psychedelics Penny Stocks psychedelic medicines From Benzinga Mindset Partners With Canadian Psychiatric Research Hospital For Preclinical Study Of Psilocybin-Derived MSP-1014 June 22, 2022 Tickers MSSTF Tags WHO Markets General From Benzinga Mindset Approved For Patent Application Involving Psilocin Derivatives For Central Nervous System Disorders June 10, 2022 Tickers MSSTF Tags Psychedelics Legal the United States Patent and Trademark Office From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.